Buy MT-1 10mg Peptide: The Advanced Linear Melanocortin Agonist
Elevating Dermatological Research with the MT-1 10mg Peptide
As the global scientific community continues to meticulously map the profound complexities of the human dermatological system, cellular pigmentation, and the precise biochemical responses to ultraviolet (UV) radiation, the demand for highly targeted, structurally stable molecular tools has exponentially increased. Enter the MT-1 10mg Peptide (Melanotan I), an industry-leading synthetic analogue designed specifically to support rigorous, high-level in-vitro laboratory analysis, targeted melanocyte cell modeling, and precision dermatological screening.
This highly stable, lyophilized powder represents a foundational, highly fascinating achievement in targeted melanocortin biochemistry. While much of the past decade’s research has frequently utilized the cyclic MT-II variant for broad-spectrum receptor agonism, the MT-1 10mg Peptide allows independent researchers and advanced testing facilities to study the profound, isolated effects of the Melanocortin-1 Receptor (MC1R). By acting as a highly specific, linear α-MSH analogue, it enables laboratories to observe the natural transcription and synthesis mechanisms of melanocytes without triggering the off-target neurological or metabolic pathways associated with broader melanocortin agonists.
What truly sets this specific listing apart for the advanced laboratory is its highly precise, industry-standard volume and absolute receptor selectivity. By providing a specifically measured 10mg dosage in a sterile, vacuum-sealed glass vial, the MT-1 10mg Peptide offers the perfect, standardized material for laboratories conducting isolated control experiments, specialized single-run cellular assays, or establishing precise comparative baselines for in-vitro phototoxicity models. This 10mg yield allows researchers to rigorously test complex pigmentation and DNA-repair hypotheses on specialized cell lines without committing to massive industrial volumes, ensuring highly efficient use of laboratory resources and maintaining absolute structural purity for localized, individual experiments.
The Biochemical Engineering of the MT-1 10mg Peptide
To truly understand the profound analytical and research value of the MT-1 10mg Peptide, scientists must first deeply examine its brilliant structural engineering. The molecule is fundamentally a synthetic, linear 13-amino-acid polypeptide. It is specifically engineered to be an incredibly potent, enzymatically stable analogue of naturally occurring alpha-melanocyte-stimulating hormone (α-MSH).
In natural biological systems, endogenous α-MSH is produced in the pituitary gland and secreted into the bloodstream to regulate melanogenesis (the production of pigment). However, native human α-MSH is notoriously unstable in laboratory environments. It possesses an extremely short half-life (often just minutes) due to rapid, aggressive enzymatic degradation by circulating proteases. This makes native α-MSH practically useless for extended in-vitro assays, as it breaks down before researchers can gather meaningful, long-term observational data on melanocyte activation.
The MT-1 10mg Peptide circumvents this biological limitation through two highly specific, masterfully executed amino acid substitutions within the native 13-chain sequence.
First, the biochemists replaced the naturally occurring Methionine at position 4 with Norleucine (Nle). Methionine is highly susceptible to oxidative damage, which quickly neutralizes the biological activity of the native hormone. By substituting the oxidatively stable Norleucine, the peptide is shielded from reactive oxygen species within the cell culture.
Second, the naturally occurring L-Phenylalanine at position 7 was replaced with its D-isomer, D-Phenylalanine (D-Phe). This specific enantiomeric shift alters the spatial geometry of the peptide just enough to render it invisible to the specific proteolytic enzymes that normally cleave and destroy the native hormone, without reducing its binding affinity to the target receptor.
Through these two precise modifications (creating the sequence [Nle4, D-Phe7]-α-MSH), researchers created the MT-1 10mg Peptide. It retains the linear structure of the native hormone—unlike MT-II, which is artificially forced into a cyclic ring—but boasts an extended half-life and an exponential increase in binding potency. This construction provides researchers with an incredibly precise, highly reactive MC1R agonist that can be utilized in extended petri-dish assays and cell culture incubations.
Synergistic Mechanisms: Targeted MC1R Agonism and Melanogenesis
The clinical and analytical value of the MT-1 10mg Peptide as a primary research tool lies entirely in its nature as a highly potent, exceptionally selective agonist of the Melanocortin-1 Receptor (MC1R). Unlike MT-II, which binds aggressively to MC3R, MC4R, and MC5R (triggering neurological, sexual, and metabolic responses), MT-1 is heavily biased toward MC1R, which is expressed almost exclusively on the surface of melanocytes in the epidermis.
When introduced to complex dermatological cell cultures, the MT-1 10mg Peptide exerts its massive biological influence through highly researched, localized physiological pathways.
The Adenylate Cyclase and cAMP Cascade
The primary, direct function of the MT-1 10mg Peptide is its aggressive binding to the MC1R on the surface of isolated melanocytes. MC1R is a classic G-protein-coupled receptor (GPCR).
When researchers apply this specific linear peptide to isolated melanocyte cultures, the binding event triggers a massive, highly orchestrated intracellular signaling cascade. It powerfully activates the G-alpha-s subunit, which directly stimulates the membrane-bound enzyme adenylate cyclase. This enzyme rapidly converts intracellular ATP into cyclic AMP (cAMP), dramatically elevating the intracellular levels of this critical secondary messenger.
This rapid surge in cAMP subsequently activates Protein Kinase A (PKA). The targeted activation of PKA acts as the master switch for the entire pigment-producing factory of the cell. The PKA complex travels directly to the cell nucleus to bind to the cAMP response element-binding protein (CREB), which actively stimulates the genetic transcription of the Microphthalmia-associated transcription factor (MITF).
Tyrosinase Activation and Eumelanin Synthesis
MITF is the master regulator of melanocyte survival and pigment production. Once activated by the MT-1 10mg Peptide, MITF rapidly drives the expression of three critical enzymes: Tyrosinase, Tyrosinase-related protein 1 (TRP-1), and Tyrosinase-related protein 2 (TRP-2).
Tyrosinase is the absolute rate-limiting enzyme in melanogenesis. It sits within specialized intracellular organelles called melanosomes and catalyzes the conversion of the amino acid L-tyrosine into L-DOPA, and subsequently into dopaquinone.
In advanced in-vitro assays, laboratories utilize the MT-1 10mg Peptide to study this exact stoichiometry. Crucially, the activation of MC1R by this peptide specifically drives the production of eumelanin (the highly photoprotective, dark brown/black pigment) rather than pheomelanin (the lighter, red/yellow pigment that can actually generate toxic free radicals under UV exposure). Researchers can extract the melanosomes from the treated cell cultures to measure the exact ratio of eumelanin to pheomelanin, providing vital data on how the peptide forces the cell to produce biologically protective shields.
Intracellular DNA Repair and Photoprotection Modeling
While stimulating pigment production is its most visually obvious mechanism, the profound secondary analytical application of the MT-1 10mg Peptide involves the modeling of intracellular DNA repair.
Modern dermatological biochemistry has revealed that MC1R activation does more than just produce melanin; it actively regulates the cell’s response to extreme oxidative stress and ultraviolet radiation. When laboratories introduce the MT-1 10mg Peptide to complex, multi-tissue skin models and subsequently bombard those cultures with simulated UV radiation, they observe a massive reduction in the formation of cyclobutane pyrimidine dimers (CPDs)—the primary form of toxic DNA damage caused by UV rays.
The peptide actively enhances the nucleotide excision repair (NER) pathways within the melanocyte nucleus. Because this linear 13-amino-acid analogue provides stable, prolonged MC1R agonism, researchers can observe how the treated cells survive toxic UV exposure that would otherwise cause total cellular apoptosis in untreated control groups. This ability to stimulate cellular fortifications from the genetic level up is why this specific compound is the premier, baseline choice for laboratories studying complex phototoxicity, erythropoietic protoporphyria (EPP) modeling, and the fundamental biochemistry of dermatological survival pathways.
Verifiable Science Supporting the MT-1 10mg Peptide
The complex biochemical mechanisms, precise structural modifications, and profound MC1R-selective signaling of linear α-MSH analogues are extensively documented in modern, heavily peer-reviewed scientific literature. Researchers investigating the fundamental properties of these highly advanced 13-amino-acid chains can find thousands of published studies detailing their physiological effects on isolated melanocyte cell lines, targeted epidermal cultures, and highly complex dermatological models.
For highly authoritative, peer-reviewed data regarding the exact receptor-binding profiles, structural mapping, and vast physiological reach of the [Nle4, D-Phe7]-α-MSH sequence, researchers are highly encouraged to review extensive physiological studies via the National Center for Biotechnology Information (NCBI). Accessing this foundational research provides a rock-solid, verifiable scientific baseline for laboratories planning to utilize the MT-1 10mg Peptide in their own novel analytical, photoprotective, and targeted baseline experiments.
Ideal In-Vitro Applications for the MT-1 10mg Peptide
Because of its unparalleled structural precision, highly selective approach to the MC1R receptor, and its highly versatile, industry-standard 10mg vial volume, the MT-1 10mg Peptide is incredibly adaptable and can be deployed in a vast variety of precision in-vitro assays. Laboratories purchasing this advanced compound frequently utilize it for the following primary research models:
-
Standardized Melanocyte Pigmentation Assays: Utilizing the 10mg precision vial to apply exact, standardized aliquots of the peptide to isolated human or murine melanocyte cultures. Researchers measure the exact rate of tyrosinase activation and the subsequent intracellular accumulation of eumelanin over extended incubation blocks.
-
UV-Radiation and Phototoxicity Modeling: Applying the MT-1 10mg Peptide to three-dimensional epidermal models prior to subjecting them to controlled doses of UVA and UVB radiation. Laboratories track the reduction in oxidative stress markers, the preservation of cellular membranes, and the active repair of pyrimidine dimers within the cellular DNA.
-
Receptor Selectivity and Competitive Assays: Applying the compound alongside known selective MC1R antagonists (like Agouti signaling peptide) in targeted batches. This allows researchers to map competitive binding kinetics, calculating precise IC50 (half-maximal inhibitory concentration) values to isolate the specific balance of the melanocortin system without the confounding variables of MC3R/MC4R activation.
-
Intracellular cAMP and Tyrosinase Quantification: Extracting cellular material from targeted, peptide-treated cultures to perform highly advanced quantitative assays. Laboratories measure the acute, rapid accumulation of cAMP using FRET sensors, and utilize Western blotting to quantify the exact up-regulation of MITF, TRP-1, and TRP-2 proteins.
Independent Laboratory Testing and Purity Standards for the MT-1 10mg Peptide
At Orbitrex, we intrinsically understand that your advanced analytical research data is only as accurate, reproducible, and strictly reliable as the raw materials you test. If a complex synthetic peptide contains micro-impurities, excess salts, incomplete amino acid substitutions, or degraded molecular debris, it will instantly introduce unpredictable variables into your research, effectively rendering your expensive analytical data completely useless.
This is precisely why we guarantee that every single batch of our MT-1 10mg Peptide undergoes the most rigorous, independent third-party testing available before it is ever cleared for distribution to the scientific community.
Our primary testing methodologies include High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS). The HPLC analysis ensures that the molecular weight and retention time of the powder perfectly match the exact profile of pure, linear α-MSH analogues, successfully separating out any potential biological contaminants, leftover manufacturing solvents, or truncated, biologically inactive peptide debris.
The Mass Spectrometry confirms the exact 13-amino-acid sequence of the peptide and specifically verifies the precise incorporation of the crucial Norleucine and D-Phenylalanine modifications. Manufacturing a highly stable linear peptide requires immense biochemical precision; our LC-MS testing guarantees there are no missing, swapped, or malformed links anywhere within the intricate molecular structure.
We mandate strictly >99% purity for the MT-1 10mg Peptide, ensuring your laboratory receives uncompromised materials entirely free from binders, heavy metals, synthetic impurities, or leftover manufacturing byproducts. When you source your complex dermatological materials from Orbitrex, you are sourcing absolute, verifiable reliability.
Preparation and Handling of the MT-1 10mg Peptide
Due to the highly fragile molecular structure of extended, 13-amino-acid synthetic chains, the proper preparation, reconstitution, and storage of the MT-1 10mg Peptide are absolutely critical to maintaining its analytical efficacy and preventing rapid degradation prior to your planned cellular experiments.
The product is shipped as a lyophilized (freeze-dried) solid powder puck inside a sterile, vacuum-sealed glass vial. Lyophilization removes the water from the peptide solution under extremely low temperature and pressure, which stabilizes the fragile molecular bonds and allows the MT-1 10mg Peptide to survive the domestic shipping process without rapid degradation, spontaneous aggregation, or structural collapse.
Reconstitution Protocols
To prepare the MT-1 10mg Peptide for in-vitro application, the powder must be carefully reconstituted into a liquid solution. Because this is an industry-standard 10mg precision vial, researchers must carefully calculate the required volume of diluent to achieve their desired microgram-per-milliliter concentration (e.g., adding 2.0mL of diluent will yield a highly concentrated 5mg/mL solution, or 1.0mL for a dense 10mg/mL baseline yield). It is highly recommended to use sterile bacteriostatic water (water containing 0.9% benzyl alcohol) or sterile saline, depending entirely on the specific chemical requirements, osmolality, and pH sensitivities of your specific melanocyte cell culture.
When introducing the diluent into the vial containing the MT-1 10mg Peptide, standard sterile laboratory protocols must be strictly observed:
-
Swab the rubber stopper of both the peptide vial and the diluent vial with 70% isopropyl alcohol to ensure complete, uncompromised sterility.
-
Using a sterile syringe, draw the exact desired volume of diluent required for your specific baseline assays.
-
Inject the diluent extremely slowly into the peptide vial. Crucial: Direct the stream of the liquid against the inner glass wall of the vial rather than shooting it directly into the lyophilized powder puck. The force of a direct, high-pressure liquid stream can physically shear the delicate, 13-chain peptide bonds of the MT-1 10mg Peptide, irreparably damaging the molecules before they are ever utilized in your expensive cellular assays.
-
Do not shake the vial under any circumstances. Vigorous shaking will destroy the amino acid sequences and violently disrupt the structural stability of the entire molecule. Gently swirl or roll the vial between your fingers until the powder has completely dissolved into a perfectly clear, uniform solution.
Storage Guidelines for the MT-1 10mg Peptide
Maintaining the molecular integrity of the MT-1 10mg Peptide post-reconstitution is paramount to the success, accuracy, and reproducibility of your highly targeted research blocks.
Unreconstituted (Lyophilized Powder): If you are not utilizing the peptide immediately upon delivery, the dry powder should be stored away from direct sunlight in a completely dry, temperature-controlled environment. For short-term storage (up to 30 days), standard room temperature is acceptable, though refrigeration is always strongly preferred. For long-term storage (up to 24 months), the lyophilized vials must be kept in a dedicated laboratory freezer at -20°C.
Reconstituted (Liquid Solution): Once bacteriostatic water or saline has been introduced to the MT-1 10mg Peptide, the structural degradation clock begins ticking immediately. Because this is a highly active 13-amino-acid chain designed for baseline testing, storage protocols must be incredibly strict. The reconstituted vial must be immediately refrigerated at 2°C to 8°C (36°F to 46°F). Even when kept at precise, temperature-controlled refrigerated settings, the mixed solution must be utilized in your laboratory assays within 20 to 30 days. Beyond this tight window, the delicate 13-chain peptide will begin to naturally degrade, losing its biological potency, breaking down into unusable fragments, and inevitably skewing your vital analytical baseline data.
Disclaimer: All products listed by Orbitrex, including the MT-1 10mg Peptide, are sold strictly for in-vitro laboratory research and analytical purposes only. They are not intended for human consumption, ingestion, diagnostic, therapeutic, or agricultural use. Our products are not FDA-approved for human use. Any communications implying human use, tanning, cosmetic application, clinical trials on unapproved human subjects, or bodily injection will result in the immediate cancellation of your account and permanent restriction from our supply chain. All researchers must adhere to their local institutional review board (IRB) guidelines when handling these research materials.
